Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications

Abstract Valerian root (Valeriana officinalis) is a popular and widely available herbal supplement used to treat sleeping disorders and insomnia. The herb’s ability to ameliorate sleep dysfunction may signify an unexplored anti-tumorigenic effect due to the connection between circadian factors and t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fengqin Shi, Ya Li, Rui Han, Alan Fu, Ronghua Wang, Olivia Nusbaum, Qin Qin, Xinyi Chen, Li Hou, Yong Zhu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ea22675247ee4e4f92a234176d4886ff
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ea22675247ee4e4f92a234176d4886ff
record_format dspace
spelling oai:doaj.org-article:ea22675247ee4e4f92a234176d4886ff2021-12-02T14:16:34ZValerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications10.1038/s41598-021-81620-x2045-2322https://doaj.org/article/ea22675247ee4e4f92a234176d4886ff2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-81620-xhttps://doaj.org/toc/2045-2322Abstract Valerian root (Valeriana officinalis) is a popular and widely available herbal supplement used to treat sleeping disorders and insomnia. The herb’s ability to ameliorate sleep dysfunction may signify an unexplored anti-tumorigenic effect due to the connection between circadian factors and tumorigenesis. Of particular interest are the structural similarities shared between valeric acid, valerian's active chemical ingredient, and certain histone deacteylase (HDAC) inhibitors, which imply that valerian may play a role in epigenetic gene regulation. In this study, we tested the hypothesis that the circadian-related herb valerian can inhibit breast cancer cell growth and explored epigenetic changes associated with valeric acid treatment. Our results showed that aqueous valerian extract reduced growth of breast cancer cells. In addition, treatment of valeric acid was associated with decreased breast cancer cell proliferation, migration, colony formation and 3D formation in vitro in a dose- and time-dependent manner, as well as reduced HDAC activity and a global DNA hypomethylation. Overall, these findings demonstrate that valeric acid can decrease the breast cancer cell proliferation possibly by mediating epigenetic modifications such as the inhibition of histone deacetylases and alterations of DNA methylation. This study highlights a potential utility of valeric acid as a novel HDAC inhibitor and a therapeutic agent in the treatment of breast cancer.Fengqin ShiYa LiRui HanAlan FuRonghua WangOlivia NusbaumQin QinXinyi ChenLi HouYong ZhuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Fengqin Shi
Ya Li
Rui Han
Alan Fu
Ronghua Wang
Olivia Nusbaum
Qin Qin
Xinyi Chen
Li Hou
Yong Zhu
Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications
description Abstract Valerian root (Valeriana officinalis) is a popular and widely available herbal supplement used to treat sleeping disorders and insomnia. The herb’s ability to ameliorate sleep dysfunction may signify an unexplored anti-tumorigenic effect due to the connection between circadian factors and tumorigenesis. Of particular interest are the structural similarities shared between valeric acid, valerian's active chemical ingredient, and certain histone deacteylase (HDAC) inhibitors, which imply that valerian may play a role in epigenetic gene regulation. In this study, we tested the hypothesis that the circadian-related herb valerian can inhibit breast cancer cell growth and explored epigenetic changes associated with valeric acid treatment. Our results showed that aqueous valerian extract reduced growth of breast cancer cells. In addition, treatment of valeric acid was associated with decreased breast cancer cell proliferation, migration, colony formation and 3D formation in vitro in a dose- and time-dependent manner, as well as reduced HDAC activity and a global DNA hypomethylation. Overall, these findings demonstrate that valeric acid can decrease the breast cancer cell proliferation possibly by mediating epigenetic modifications such as the inhibition of histone deacetylases and alterations of DNA methylation. This study highlights a potential utility of valeric acid as a novel HDAC inhibitor and a therapeutic agent in the treatment of breast cancer.
format article
author Fengqin Shi
Ya Li
Rui Han
Alan Fu
Ronghua Wang
Olivia Nusbaum
Qin Qin
Xinyi Chen
Li Hou
Yong Zhu
author_facet Fengqin Shi
Ya Li
Rui Han
Alan Fu
Ronghua Wang
Olivia Nusbaum
Qin Qin
Xinyi Chen
Li Hou
Yong Zhu
author_sort Fengqin Shi
title Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications
title_short Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications
title_full Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications
title_fullStr Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications
title_full_unstemmed Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications
title_sort valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/ea22675247ee4e4f92a234176d4886ff
work_keys_str_mv AT fengqinshi valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications
AT yali valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications
AT ruihan valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications
AT alanfu valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications
AT ronghuawang valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications
AT olivianusbaum valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications
AT qinqin valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications
AT xinyichen valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications
AT lihou valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications
AT yongzhu valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications
_version_ 1718391699385876480